Abbott, J&J results buoyed by surprising June uptick in medical procedures even as coronavirus cases rise

Abbott Laboratories and Johnson & Johnson separately reported earlier-than-expected recoveries of elective procedures in American hospitals in the second quarter, even as the nation struggles with a worsening COVID-19 pandemic.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.